Mumbai-based Cipla faces massive income tax demand of ₹774 crore over rule violations, including short deductions and disallowance of expenses, amid the launch of its new obesity drug.
CiplaIncome Tax DemandRule ViolationsObesity DrugPharmaceutical IndustryReal Estate MumbaiJul 16, 2024
The income tax demand on Cipla is ₹774 crore.
The tax authorities have cited rule violations, including short deductions, weighted deductions, and disallowance of expenses.
Cipla has stated that the tax demands are not applicable under the law and plans to appeal against the tax order.
The income tax demand on Cipla is significant as it comes at a time when the company is preparing to launch a new obesity drug, and may impact its financial performance.
Cipla remains committed to its mission of providing affordable and innovative healthcare solutions to patients globally, despite the income tax demand.
The incident occurred at around 10:45 pm on Wednesday, and the injured people have been admitted to the hospital for treatment.
A recent report by Grihum Housing Finance highlights a significant 28% growth in the luxury housing sector during Q1 2025, driven by the emergence of micro-markets across key cities like Delhi-NCR, Mumbai, and Bangalore.
Explore the most promising investment themes for 2025, covering sectors like real estate, stocks, and more. Stay ahead of the market trends and make informed decisions.
Discover how the revised Short Term and Long Term Capital Gains tax rates affect your real estate investments.
Several prominent companies, including Titan, Swiggy, Tata Power, Aadhaar Housing, and Whirlpool, are expected to be in the spotlight ahead of the market opening. Here's a detailed look at their recent performance and upcoming events.
Following a slow first half, Indian real estate developers, including major Bengaluru players like Prestige, Puravankara, Sobha, and Brigade, are preparing for a flurry of project launches in the second half of the financial year 2025.